TABLE 4.
Biomarker | Cases* FEV1 Less Than LLN | Control Subjects* FEV1 Greater Than or Equal to LLN | P Value† |
Metabolic syndrome‡ | 0.27 (19/71) | 0.16 (26/166) | 0.07 |
Triglycerides ≥150 mg/dl | 0.51 (36/71) | 0.46 (76/166) | 0.57 |
HDL<40 mg/dl | 0.32 (23/71) | 0.20 (33/166) | 0.05 |
HDL<40 and triglycerides ≥150 mg/dl | 0.28 (20/71) | 0.14 (23/166) | 0.006 |
Glucose ≥100 mg/dl | 0.28 (20/71) | 0.16 (26/166) | 0.03 |
Heart rate ≥66 bpm | 0.65 (46/71) | 0.48 (79/166) | 0.02 |
BMI ≥30 kg/m2 | 0.32 (23/71) | 0.26 (43/166) | 0.34 |
Leptin ≥10,300 pg/ml§ | 0.42 (30/71) | 0.21 (34/166) | 0.001 |
Pancreatic polypeptide ≤89 pg/ml‖ | 0.38 (27/71) | 0.24 (40/166) | 0.04 |
Amylin ≥116 pg/ml§ | 0.07 (5/71) | 0.31 (51/166) | ≤0.0001 |
Definition of abbreviations: BMI = body mass index; HDL = high-density lipoprotein; LLN = lower limit of normal as defined by NHANES III; NHANES = National Health and Nutrition Examination Survey.
Proportions in group (n in group/total).
P value determined by Pearson chi-square.
National Heart Lung and Blood Institute/American Heart Association Criteria.
Values were represented as top quartiles.
Values were represented as bottom quartiles.